|
North American Plan For Animal and Pandemic Influenza
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
North American Plan for Avian and Pandemic Influenza (NAPAPI) is a comprehensive document designed to prepare for avian and pandemic influenza in North America. Coordinated by the Division of International Health Security in the Office of Policy and Planning at the Office of the Assistant Secretary for Preparedness and Response (ASPR), NAPAPI working groups bring together subject matter experts from the U.S., Canada and Mexico to address policy issues involving pandemic influenza. Output from NAPAPI working groups is integrated into updates of the 2012 NAPAPI document.
|
|
Northwest Portland Tribal Registry Project
|
Resource Development
|
IHS
|
NCI
|
Over the past 10 years, health care delivery for Northwest American Indians and Alaska Natives has evolved from a centralized system maintained by the Indian Health Service (IHS) to a diverse and complex environment. The Northwest Tribal Registry Project was developed in January 1999 by the Northwest Tribal Epidemiology Center, a tribally operated program located at the Northwest Portland Area Indian Health Board (NPAIHB) in Portland, Oregon.
|
|
Nutrition Coordinating Committee (NCC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
NIDDK, CC, CIT, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD/DPCPSI, OD/DPCPSI/OBSSR
|
The Nutrition Coordinating Committee (NCC) operates as an National Institutes of Health (NIH)-wide forum to review, stimulate, and encourage the support of nutrition research and training to better define the role of nutrition in the promotion and maintenance of health and in the prevention and treatment of disease. The NCC also plays a key role in the development of nutrition research policy at the NIH. NCC membership includes a representative and alternate from the 20 NIH Institutes and 7 Centers. In addition, offices and agencies within the U. S. Department of Health and Human Services (HHS), U.S. Department of Agriculture (USDA), and the Department of Defense (DOD) have also appointed liaison representatives to the Committee. The NCC meets monthly to provide an open forum for members to report on current and future nutrition research, policy activities, and research funding and training opportunities.
|
|
Occupational Exposure to Bisphenol A in the United States
|
Research Initiative
|
CDC
|
NIEHS
|
The purpose of this project is to assess occupational exposure to bisphenol A (BPA) in a cross-section of industries and jobs where BPA is either produced or processed.
|
|
Office for Human Research Protections/Office of Extramural Research Training Initiative
|
Meeting/ Workshop
|
OS
|
OD/OER
|
The National Institutes of Health (NIH) Office of Extramural Research (OER) collaborated with the Office for Human Research Protections (OHRP) to provide comprehensive training at both NIH Regional Meetings for the extramural community and to NIH staff on Human Research Participant Protections.
|
|
Office of AIDS Research Advisory Council (OARAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/DPCPSI/OAR, NICHD
|
The Office of AIDS Research Advisory Council (OARAC) provides advice to the Director of the Office of AIDS Research (OAR) on the planning, coordination, and evaluation of research and other activities in respect to AIDS conducted or supported by the National Institutes of Health (NIH). OARAC also advises the Secretary of Health and Human Services, the Assistant Secretary for Health, the Director of NIH, and the Director of OAR, on AIDS research programs, the development and annual review of the comprehensive plan for the conduct and support of all AIDS activities of the Institutes and Centers of NIH, including research policies and priorities, and the coordination of domestic and international NIH AIDS efforts.
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA, OSG
|
NIBIB, NCI
|
Coordinate the efforts of multiple stakeholders (U.S. Department of State (State), U.S. Department of Energy (DoE), Department of Homeland Security (DHS), U. S. Department of Health and Human Services (HHS), private sector) to establish a stable, long-term domestic supply of Mo99 (molybdenum-99) for medical purposes. Such a supply needs to be consistent with current international goals (to which the US is an active participant) of reduction in the use of high-enriched uranium in all reactors, including Mo99 production facilities, as well as full cost recovery solutions.
|
|
Oral Health, Cancer Care, and You
|
Public Education Campaign
|
CDC
|
NIDCR, NCI, NINR
|
A series of publications to inform health care providers and patients about steps they can take before, during, and after cancer treatment to reduce the risk and impact of the often painful side effects.
|
|
Osteoporosis and Related Bone Diseases—National Resource Center
|
Resource Development
|
OS
|
NIAMS, NIA, NICHD, NIDCR, NIDDK, OD/DPCPSI/ORWH
|
Provides patients, health professionals, and the public with an important link to resources and information on metabolic bone diseases, including osteoporosis, Paget’s disease of the bone, and osteogenesis imperfecta.
|
|
Package and Distribution of Nutritional Biochemistry for AREDS 2
|
Research Initiative
|
OS
|
NEI
|
The Age-Related Eye Disease Study II (AREDS2) is a multi-center randomized trial designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and/or omega-3 Long-Chain Polyunsaturated Fatty Acids (LCPUFAs; DHA and EPA) for the treatment of Age-Related Macular Degeneration (AMD) and cataract. The primary objective of AREDS2 is to evaluate the effect of dietary xanthophylls (lutein/zeaxanthin) and/or omega-3 LCPUFAs (DHA and EPA) on progression to advanced AMD. This objective will be accomplished by collecting and assessing the data on approximately 4,000 AREDS2 participants aged 50 to 85 years, who at the time of enrollment have either: 1) bilateral large drusen or 2) large drusen in one eye and advanced AMD (neovascular AMD or central geographic atrophy) in the fellow eye.
|